MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc Oct 02-04, 2026

$100.00

MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc Oct 02-04, 2026

$100.00

MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc Oct 02-04, 2026

Name: MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc Oct 02-04, 2026
Brand: Amboss
SKU: MED-AMB10547
Price: 100.00 USD
Availability: InStock

MER Primary Care Conferences 2026 | Internal Medicine, Dermatology, Gastroenterology, Oncology, Colorectal Cancer Screening, Hepatitis, Skin Lesions & Cancer Prevention

The MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc Oct 02-04, 2026 program provides a comprehensive, evidence-based educational update on common and complex conditions encountered in adult primary care medicine. Organized by Medical Education Resources (MER), this three-day continuing medical education conference integrates important clinical developments across dermatology, gastroenterology, oncology, and general internal medicine. Held October 2–4, 2026, at the Holiday Inn Estes Park near Rocky Mountain National Park, Colorado, the program emphasizes practical diagnostic approaches, current treatment recommendations, preventive medicine, clinical procedures, and appropriate specialty referral. The MER Internal Medicine for Primary Care Dermatology Gastroenterology Oncology 2026 curriculum covers lower gastrointestinal bleeding, colorectal cancer screening and surveillance, celiac disease, chronic diarrhea, hepatitis B and C management, skin manifestations of systemic disease, acneiform eruptions, benign and malignant skin tumors, cancer prevention, evaluation of suspected malignancy, cancer survivorship, and oral anticoagulation. Through 12 focused educational presentations, clinicians review important medical conditions that frequently overlap across primary care and specialty medicine. The program is designed to help office-based healthcare professionals improve diagnostic accuracy, understand evolving clinical recommendations, recognize serious disease presentations, and select appropriate management strategies.

Course Details

Course: MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc Oct 02-04, 2026
Official Program: Internal Medicine for Primary Care: Dermatology/Gastroenterology/Oncology
Organizer: Medical Education Resources (MER)
Dates: October 2–4, 2026
Location: Rocky Mountain National Park Area, Colorado, USA
Venue: Holiday Inn Estes Park
Venue Address: 101 S. St. Vrain Avenue, Estes Park, Colorado 80517
Official Conference Format: In-Person
Duration: Three Days
Primary Specialty: Internal Medicine / Primary Care
Additional Focus: Dermatology, Gastroenterology, Hepatology, Oncology, Hematology and Preventive Medicine
Language: English
Published Educational Lectures: 12
Official AMA CME: Up to 12 AMA PRA Category 1 Credits™
ABIM MOC: Up to 12 Points
AAFP Credit: Up to 12 Live AAFP Prescribed Credits
ANCC Nursing Credit: Up to 12 Contact Hours
ANCC Pharmacotherapeutic Credit: 5.5 Contact Hours
IPCE: 12 Credits
AAPA CME: Up to 12 Category 1 CME Credits

The credits described above apply to eligible participation in the original MER live conference and do not accompany separately purchased MedicalAmboss educational files.

Target Audience

The program is designed for office-based primary care practitioners and other healthcare professionals seeking practical updates in adult outpatient medicine. The target audience includes:

Internal Medicine Physicians
General Internists
Family Medicine Physicians
Primary Care Physicians
General Practitioners
Gastroenterologists
Hepatologists
Dermatologists
Medical Oncologists
Hematologists
Surgical Oncologists
Preventive Medicine Physicians
Hospitalists
Physician Assistants
Nurse Practitioners
Registered Nurses
Advanced Practice Providers
Medical Residents
Clinical Fellows
Other Healthcare Professionals Involved in Primary Care

The program is especially relevant to clinicians responsible for evaluating gastrointestinal complaints, liver disease, skin lesions, cancer-related symptoms, and long-term survivorship needs.

Program Overview

Primary care physicians frequently encounter patients with symptoms that require knowledge spanning multiple medical specialties. Abdominal bleeding, chronic diarrhea, abnormal liver tests, skin eruptions, suspicious lesions, cancer-related symptoms, and anticoagulant use can create significant diagnostic and therapeutic challenges. The MER Primary Care Conferences Derm/Gastro/Onc 2026 program addresses these challenges through multidisciplinary educational sessions. The curriculum covers:

Lower Gastrointestinal Bleeding
Occult Blood Testing
Hematochezia
Colorectal Cancer Screening
Colorectal Cancer Surveillance
Colonoscopy Recommendations
Celiac Disease
Chronic Diarrhea
Malabsorption
Hepatitis B
Hepatitis C
Chronic Liver Disease
Skin Manifestations of Systemic Disease
Acne
Acneiform Eruptions
Folliculitis
Hidradenitis Suppurativa
Rosacea
Benign Skin Tumors
Skin Biopsy Techniques
Premalignant Skin Lesions
Basal Cell Carcinoma
Squamous Cell Carcinoma
Melanoma
Cancer Prevention
Evaluation of Suspected Cancer
Cancer Survivorship
Cancer Recurrence Surveillance
Direct Oral Anticoagulants
Perioperative Anticoagulation Management
Anticoagulant Reversal

The educational program emphasizes evidence-based diagnosis, current treatment recommendations, prevention, and clinical decision-making.

Learning Objectives

Upon completion of the original educational program, participants should be better able to:

List current treatment recommendations for the management of lower gastrointestinal bleeding.
Discuss guidelines for colonoscopic colorectal cancer screening and surveillance.
Recommend appropriate testing for the evaluation of celiac disease.
List current treatment recommendations for hepatitis B virus (HBV) and hepatitis C virus (HCV).
Identify cutaneous findings that may serve as clinical indicators of underlying internal diseases.
Describe a stepwise approach to the diagnosis and treatment of acne and acneiform eruptions.
Differentiate benign and malignant skin tumors and employ appropriate office-based dermatologic procedures.
Detect premalignant and malignant skin lesions.
Identify clinical practices shown to prevent cancer.
Discuss the diagnostic approach to patients with suspected malignancy.
Evaluate and manage important medical risks associated with cancer survivorship.
Manage patients receiving newer oral anticoagulant medications.

Official Program Topics

Day 1 – Friday, October 2, 2026

All times are local Mountain Time.

Session I – Gastroenterology

Management of Lower GI Bleeding – From Occult to Massive

7:30 AM – 8:30 AM This presentation reviews the clinical evaluation and management of lower gastrointestinal bleeding, ranging from occult blood loss to major hematochezia. Lower GI bleeding is an important clinical presentation that may require careful evaluation to determine the source, severity, and urgency of intervention. Important considerations include:

Lower Gastrointestinal Bleeding
Occult GI Bleeding
Hematochezia
Clinical History
Hemodynamic Assessment
Diagnostic Evaluation
Fecal Occult Blood Testing
Interpretation of Stool Blood Tests
Colonic Bleeding Sources
Diagnostic and Therapeutic Strategies
Risk Stratification
Appropriate Referral
Management of Severe Bleeding

The session emphasizes selecting appropriate diagnostic and management approaches according to clinical presentation and bleeding severity.

Colorectal Cancer Screening and Surveillance

8:30 AM – 9:30 AM This session reviews current colorectal cancer screening recommendations for average-risk individuals and the role of surveillance following abnormal findings. Important topics include:

Colorectal Cancer Prevention
Screening Eligibility
Average-Risk Adults
Colonoscopy
Stool-Based Screening
Screening Intervals
Surveillance Colonoscopy
Adenomatous Polyps
Risk-Based Follow-Up
Benefits and Limitations of Screening
Patient Counseling
Shared Decision-Making

The educational emphasis is on applying current colorectal cancer screening recommendations and determining appropriate follow-up.

Celiac Disease and Chronic Diarrhea

9:40 AM – 10:40 AM This presentation examines the diagnostic evaluation of chronic diarrhea and malabsorption, with emphasis on celiac disease. Although gluten-free diets have become increasingly common, not every patient following a gluten-free diet has confirmed celiac disease. Important considerations include:

Celiac Disease
Chronic Diarrhea
Malabsorption
Gluten-Related Disorders
Diagnostic Serology
Tissue Transglutaminase Antibodies
Total Immunoglobulin A
Duodenal Biopsy
Differential Diagnosis
Diagnostic Challenges During Gluten Restriction
Nutritional Deficiencies
Appropriate Testing
Gastroenterology Referral

The session addresses how clinicians should approach diagnostic testing when patients have already begun avoiding gluten.

Session II – Dermatology

Skin Manifestations of Systemic Disease

10:40 AM – 11:40 AM Skin findings may reflect underlying systemic illnesses or complications of medical treatment. This presentation reviews the importance of recognizing cutaneous signs that may provide diagnostic clues to internal disease. Important topics include:

Cutaneous Manifestations
Systemic Disease
Rheumatologic Disorders
Endocrine Disorders
Gastrointestinal Disease
Inflammatory Conditions
Medication-Related Skin Changes
Dermatologic Examination
Differential Diagnosis
Recognition of Internal Disease
Appropriate Investigations
Specialist Referral

The session emphasizes integrating dermatological findings into broader medical assessment.

Acne and Acneiform Eruptions

11:40 AM – 12:40 PM This presentation provides a clinical review of acne and related dermatologic conditions commonly encountered in primary care. Important topics include:

Acne Vulgaris
Open Comedones
Closed Comedones
Inflammatory Acne
Acne Severity Assessment
Bacterial Folliculitis
Drug-Induced Acne
Hidradenitis Suppurativa
Miliaria
Perioral Dermatitis
Pseudofolliculitis Barbae
Rosacea
Seborrheic Dermatitis
Topical Treatment
Systemic Treatment
Treatment Selection
Dermatology Referral

The session emphasizes classifying acne severity and applying appropriate stepwise treatment strategies. 12:40 PM – Day 1 Session Adjournment

Day 2 – Saturday, October 3, 2026

Session III – Dermatology

Benign Skin Tumors

7:30 AM – 8:30 AM This session examines the diagnosis and treatment of common benign skin tumors. Primary care physicians frequently evaluate pigmented lesions, skin growths, and other dermatologic findings that require differentiation from malignant conditions. Important topics include:

Benign Skin Tumors
Melanocytic Nevi
Seborrheic Keratoses
Keloids
Hemangiomas
Other Benign Lesions
Clinical Examination
Diagnostic Assessment
Skin Biopsy
Histopathology
Treatment Options
Referral Indications

The session emphasizes appropriate clinical recognition and management of benign skin lesions.

Premalignant and Malignant Skin Tumors

8:30 AM – 9:30 AM This presentation reviews recognition of premalignant and malignant skin tumors and the importance of early diagnosis. Important topics include:

Actinic Keratosis
Bowen's Disease
Squamous Cell Carcinoma
Basal Cell Carcinoma
Melanoma
Suspicious Skin Lesions
Clinical Warning Signs
Premalignant Skin Conditions
Punch Biopsy
Excisional Biopsy
Histopathological Diagnosis
Skin Cancer Risk Reduction
Dermatology Referral
Patient Education

The session emphasizes early identification of suspicious skin lesions and appropriate diagnostic procedures.

Session IV – Gastroenterology and Hepatology

Hepatitis B and C Management

9:40 AM – 10:40 AM This presentation reviews important developments in the evaluation and management of viral hepatitis. The session emphasizes hepatitis B screening, vaccination, treatment considerations, and clinical management of patients with chronic liver disease. Important topics include:

Hepatitis B Virus
Hepatitis C Virus
HBV Screening
HCV Screening
Hepatitis B Vaccination
Chronic Viral Hepatitis
Diagnostic Testing
Antiviral Therapy
Chronic Liver Disease
Decompensated Liver Disease
Special Patient Populations
Liver Disease Monitoring
Hepatology Referral

The session supports appropriate evaluation and treatment planning for patients with hepatitis B or C.

Session V – Oncology

Cancer Prevention

10:40 AM – 11:40 AM This session reviews clinical practices and screening strategies intended to reduce cancer risk and improve early detection. Important topics include:

Cancer Prevention
Preventive Medicine
Cancer Risk Assessment
Cancer Screening
High-Risk Populations
Lifestyle-Related Risk Factors
Tobacco Cessation
Preventive Counseling
Evidence-Based Screening
Appropriate Follow-Up
Patient Education
Risk Reduction Strategies

The session emphasizes prevention as an essential component of primary care medicine.

Approach to the Patient with Suspected Cancer

11:40 AM – 12:40 PM This presentation reviews the clinical evaluation of patients presenting with symptoms or findings that may raise concern for malignancy. Important considerations include:

Suspected Malignancy
Clinical Warning Signs
Unexplained Symptoms
Patient History
Physical Examination
Diagnostic Testing
Laboratory Evaluation
Imaging Considerations
Differential Diagnosis
Risk Stratification
Appropriate Referral
Diagnostic Follow-Up
Multidisciplinary Evaluation

The educational emphasis is on developing a systematic clinical approach to recognizing and evaluating suspected cancer. 12:40 PM – Day 2 Session Adjournment

Day 3 – Sunday, October 4, 2026

Session VI – Oncology and Cancer Survivorship

Management of Cancer Survivors

7:30 AM – 8:30 AM This session addresses medical issues affecting patients who have completed cancer treatment and require ongoing follow-up. Cancer survivorship care may involve monitoring for disease recurrence, treatment-related complications, comorbid conditions, and long-term health risks. Important topics include:

Cancer Survivorship
Cancer Recurrence Surveillance
Follow-Up Care
Late Treatment Effects
Long-Term Complications
Cardiovascular Risk
Secondary Malignancies
Preventive Care
Chronic Disease Management
Survivorship Care Planning
Multidisciplinary Coordination
Patient Quality of Life

The presentation emphasizes the role of primary care in coordinating long-term care for cancer survivors.

A Primary Care Review of New Oral Anticoagulants

8:30 AM – 9:30 AM This session reviews important pharmacological and clinical considerations involving newer oral anticoagulant medications. Important topics include:

Direct Oral Anticoagulants
Anticoagulant Mechanisms
Clinical Indications
Treatment Selection
Therapeutic Considerations
Bleeding Risk
Perioperative Management
Drug Interactions
Anticoagulant Reversal
Antiplatelet Medications
Patient Monitoring
Individualized Anticoagulation Decisions

The educational discussion emphasizes appropriate management of oral anticoagulants in primary care practice. 9:30 AM – Conference Adjournment

Major Topics Covered

MER Primary Care Conferences 2026
Internal Medicine for Primary Care
Dermatology
Gastroenterology
Hepatology
Oncology
Hematology
Lower GI Bleeding
Occult Gastrointestinal Bleeding
Hematochezia
Colorectal Cancer Screening
Colorectal Cancer Surveillance
Colonoscopy
Celiac Disease
Chronic Diarrhea
Malabsorption
Hepatitis B
Hepatitis C
Viral Hepatitis
Benign Skin Tumors
Premalignant Skin Lesions
Malignant Skin Tumors
Basal Cell Carcinoma
Squamous Cell Carcinoma
Melanoma
Actinic Keratosis
Skin Biopsy
Dermatologic Procedures
Acne Vulgaris
Acneiform Eruptions
Rosacea
Folliculitis
Hidradenitis Suppurativa
Skin Manifestations of Systemic Disease
Cancer Prevention
Early Cancer Detection
Suspected Malignancy
Cancer Survivorship
Cancer Recurrence Surveillance
Direct Oral Anticoagulants
Anticoagulation Management
Perioperative Anticoagulation
Evidence-Based Primary Care
Clinical Diagnosis
Differential Diagnosis
Preventive Medicine

Gastrointestinal Bleeding and Diagnostic Evaluation

Lower gastrointestinal bleeding represents an important clinical challenge across primary care, gastroenterology, and emergency medicine. Patients may present with occult blood loss, intermittent bleeding, or major hematochezia. The curriculum examines diagnostic strategies and treatment considerations appropriate to different clinical presentations. Major areas include:

Recognition of Lower GI Bleeding
Assessment of Bleeding Severity
Stool Blood Testing
Diagnostic Evaluation
Risk Stratification
Appropriate Investigation
Treatment Considerations
Specialist Referral

The educational focus supports structured clinical decision-making in patients presenting with suspected gastrointestinal bleeding.

Colorectal Cancer Screening and Prevention

Colorectal cancer screening is an important component of preventive primary care. The course reviews screening recommendations and surveillance considerations relevant to patients at average risk. Important areas include:

Screening Eligibility
Colonoscopy
Stool-Based Screening Methods
Screening Intervals
Follow-Up After Abnormal Findings
Colorectal Neoplasia Prevention
Patient Counseling
Shared Decision-Making

The program emphasizes the importance of applying screening recommendations appropriately while considering individual patient circumstances.

Celiac Disease and Malabsorption

Celiac disease is an immune-mediated disorder associated with gluten exposure in genetically susceptible individuals. It may present with gastrointestinal symptoms, malabsorption, nutritional abnormalities, or less typical clinical findings. The program examines:

Chronic Diarrhea
Malabsorption
Celiac Serology
Diagnostic Testing
Gluten-Free Diet Considerations
Differential Diagnosis
Nutritional Consequences
Appropriate Referral

Particular attention is given to evaluating patients who have already adopted a gluten-free diet before undergoing diagnostic testing.

Viral Hepatitis and Liver Disease

Hepatitis B and hepatitis C remain important causes of chronic liver disease. Primary care providers play a role in screening, vaccination, initial assessment, monitoring, and referral. The educational discussion includes:

HBV Screening
HCV Screening
Hepatitis B Vaccination
Chronic Infection
Antiviral Treatment
Special Populations
Advanced Liver Disease
Clinical Monitoring
Referral to Hepatology

The session supports an evidence-informed approach to viral hepatitis management.

Dermatology and Systemic Disease

Skin findings may offer important diagnostic clues to underlying medical conditions. The curriculum examines the relationship between cutaneous manifestations and diseases affecting other organ systems. Potential clinical areas include:

Rheumatologic Disorders
Endocrine Conditions
Gastrointestinal Diseases
Inflammatory Disorders
Medication-Related Reactions
Systemic Disease Recognition

The educational emphasis is on incorporating dermatologic examination into comprehensive primary care assessment.

Acne and Common Inflammatory Skin Disorders

Acne and related inflammatory dermatologic conditions are frequently encountered in outpatient practice. The program covers diagnostic classification, clinical differentiation, and treatment selection. Important conditions include:

Acne Vulgaris
Folliculitis
Rosacea
Hidradenitis Suppurativa
Perioral Dermatitis
Drug-Induced Acne
Seborrheic Dermatitis

The session emphasizes practical treatment approaches and recognition of situations requiring specialist evaluation.

Benign and Malignant Skin Lesions

Differentiating benign from suspicious skin lesions is an important clinical responsibility. The dermatology curriculum reviews common benign tumors and major premalignant and malignant conditions. Important areas include:

Nevi
Seborrheic Keratoses
Keloids
Hemangiomas
Actinic Keratosis
Bowen's Disease
Basal Cell Carcinoma
Squamous Cell Carcinoma
Melanoma

The program emphasizes lesion assessment, appropriate biopsy selection, skin cancer prevention, and referral considerations.

Cancer Prevention and Early Diagnosis

Preventive care and early recognition of cancer are major themes of the oncology curriculum. Primary care physicians frequently identify patients who may benefit from cancer screening, preventive counseling, or additional diagnostic evaluation. Important areas include:

Cancer Risk Assessment
Screening Recommendations
Recognition of Warning Signs
Diagnostic Testing
Clinical Follow-Up
Appropriate Referral
Patient Counseling
Prevention Strategies

The educational content supports systematic evaluation and evidence-based preventive care.

Cancer Survivorship and Long-Term Follow-Up

Cancer survivors may experience ongoing healthcare needs after completion of treatment. These needs may include recurrence surveillance, management of comorbidities, treatment-related complications, and preventive care. The program examines:

Survivorship Care
Cancer Surveillance
Late Treatment Effects
Chronic Disease Management
Risk Assessment
Preventive Services
Multidisciplinary Coordination
Quality of Life

The educational focus emphasizes the continuing role of primary care in cancer survivorship.

Direct Oral Anticoagulants in Primary Care

Newer oral anticoagulants have become important treatment options in patients requiring prevention or treatment of thromboembolic disease. Their use requires consideration of clinical indications, bleeding risk, comorbidities, interactions, and procedural management. The course reviews:

Oral Anticoagulant Selection
Mechanisms of Action
Clinical Indications
Treatment Safety
Perioperative Management
Bleeding Complications
Reversal Strategies
Individualized Patient Care

These topics are relevant to internists and other clinicians managing patients receiving anticoagulation therapy.

Evidence-Based Clinical Decision-Making

The MER Primary Care Conferences Derm/Gastro/Onc 2026 program emphasizes the application of current medical evidence to everyday clinical practice. Important clinical responsibilities include:

Recognizing Important Symptoms
Establishing Differential Diagnoses
Selecting Appropriate Investigations
Applying Current Screening Recommendations
Evaluating Treatment Options
Managing Medication-Related Risks
Recognizing Urgent Conditions
Coordinating Specialty Referral
Providing Long-Term Follow-Up

The curriculum integrates clinical reasoning across dermatology, gastroenterology, oncology, and general internal medicine.

Continuing Medical Education

Medical Education Resources designated the original live educational activity for a maximum of:

12 AMA PRA Category 1 Credits™
12 ABIM MOC Points
12 Live AAFP Prescribed Credits
12 ANCC Nursing Contact Hours
5.5 ANCC Pharmacotherapeutic Contact Hours
12 AAPA Category 1 CME Credits
12 Interprofessional Continuing Education Credits
12 AOA Category 2-A Hours
12 ACEP Category I Credit Hours

Medical Education Resources is jointly accredited by ACCME, ACPE, and ANCC to provide continuing education for the healthcare team.

Important CME Notice

The credit amounts listed above apply to eligible participation in the original MER live educational activity under the organizer's requirements. Purchasing separately distributed educational files through MedicalAmboss does not provide:

Official MER CME Credits
ABIM MOC Points
Official Completion Certificates
MER Conference Registration
Live Conference Attendance
Publisher Streaming Access
Official MER Accounts
Publisher Memberships
Publisher-Hosted Educational Extras

Why This Course Is Relevant

The MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc Oct 02-04, 2026 program provides a multidisciplinary review of medical conditions commonly encountered in outpatient practice. Primary care physicians frequently evaluate patients with:

Gastrointestinal Bleeding
Chronic Diarrhea
Suspected Celiac Disease
Viral Hepatitis
Skin Manifestations of Systemic Disease
Acne and Inflammatory Skin Conditions
Benign and Suspicious Skin Lesions
Cancer Screening Needs
Symptoms Suggestive of Malignancy
Long-Term Cancer Survivorship Needs
Oral Anticoagulant Management Issues

The program emphasizes evidence-based diagnosis, appropriate investigations, current treatment recommendations, preventive care, and patient-specific management strategies. Its integration of dermatology, gastroenterology, hepatology, and oncology makes it particularly relevant to internists, family medicine physicians, gastroenterologists, dermatologists, oncologists, and other healthcare professionals involved in primary care.

Official Program Reference and MedicalAmboss Purchase Scope

Official Medical Education Resources Conference: https://www.mer.org/conference/MTIzNyxPY3RvYmVyLDIwMjY%3D/view-agenda/ Official 2026 Conference Agenda: https://www.mer.org/wp-content/uploads/2025/10/26_1002_IM_RMP_Agenda_Web_10_15_25.pdf These references describe the original October 2–4, 2026 conference, including its educational agenda, objectives, accreditation, and venue. They do not establish the exact inventory of digital files included with a separately distributed MedicalAmboss product. MedicalAmboss File Scope: This listing describes the educational subject matter for reference. Provider registration, live attendance, streaming-platform access, CME or other credit, certificates, memberships, apps, accounts, and publisher-hosted extras are not included unless explicitly listed as store files.

Short Description

<div style="border:2px solid #1677b8;border-radius:10px;padding:12px;background:#f7fbfe;"> MER Primary Care Conferences Internal Medicine for Primary Care Derm Gastro Onc 2026 provides a comprehensive, evidence-based educational review of dermatology, gastroenterology, oncology, and adult primary care medicine. Held October 2–4, 2026, in Estes Park, Colorado, the program covers lower GI bleeding, colorectal cancer screening, celiac disease, chronic diarrhea, hepatitis B and C, acneiform disorders, skin lesions, cancer prevention, suspected malignancy, survivorship care, and oral anticoagulants.

Topics

Friday, October 2, 2026
- Gastroenterology: Management of Lower GI Bleeding – From Occult to Massive (The correct use and interpretation of tests for occult blood in the stool will be discussed in relation to lower GI bleeding; focus on the utility of different diagnostic and management approaches to the spectrum of patients presenting with hematochezia)
- Gastroenterology: Colorectal Cancer Screening and Surveillance (Reviews the most recent recommendations for CRC screening in the general population at average risk for CRC)
- Gastroenterology: Celiac Disease and Chronic Diarrhea (Millions of Americans are now on a gluten free diet. Only some of them actually have Celiac disease. We will review the workup of diarrhea and malabsorption with a focus on celiac disease; We will discuss how to diagnose celiac disease when a patient is already on a gluten free diet and an appropriate differential diagnosis)
- Dermatology: Skin Manifestations of Systemic Disease (Skin will often reflect signs of systemic diseases, be useful for diagnosis, or suffer from a complication of disease or its treatment; Diagnosis of rheumatologic, endocrine, gastrointestinal, and psychologic conditions based on cutaneous findings)
- Dermatology: Acne and Acneiform Eruptions (Identification of noninflammatory open or closed comedones and inflammatory lesions; Determination of treatment therapies based on acne grading scale; Bacterial folliculitis, drug-induced acne, hidradenitis suppurativa, miliaria, perioral dermatitis, pseudofolliculitis barbae, rosacea, seborrheic dermatitis; Topical and systemic therapy)
Saturday, October 3, 2026
- Dermatology: Benign Skin Tumors (Proper diagnosis and treatment of common benign tumors; Biopsies and histopathologic examination; Nevi, seborrheic keratosis, keloids, hemangiomas and miscellaneous tumors; When to refer)
- Dermatology: Premalignant and Malignant Skin Tumors (Recognition of precursors of malignancies; Excisional and punch biopsies; Actinic keratosis, Bowen’s disease, squamous cell carcinoma, basal cell carcinoma, melanoma and other selected tumors; Risk reduction education)
- Gastroenterology: Hepatitis B and C Management (HBV screening: whom to screen, whom to vaccinate; management of patients with decompensated hepatitis B related liver disease; treatment in special populations)
- Oncology: Cancer Prevention (Cancer screening and clinical practices shown to prevent cancer will be reviewed)
- Oncology: Approach to the Patient with Suspected Cancer (Symptoms, signs and diagnoses that raise the suspicion of cancer will be reviewed, and an approach to evaluating these patients will be presented)
Sunday, October 4, 2026
- Oncology: Management of Cancer Survivors (Medical issues related to cancer survivorship and approaches to surveillance for cancer recurrence will be reviewed)
- Oncology: A Primary Care Review of New Oral Anticoagulants (Mechanisms of action, clinical indications, therapeutic indices, perioperative management and approaches to reversal of new anticoagulant and antiplatelet medications will be reviewed)